Chlorthalidone improves vertebral bone quality in genetic hypercalciuric stone-forming rats

Journal of Bone and Mineral Research

Volumn 26, Issue 8, 2011, Pages 1904-1912

  Bushinsky, David A ^a   Willett, Thomas ^b,c   Asplin, John R ^d   Culbertson, Christopher ^a   Che, Sara Py ^b   Grynpas, Marc ^b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d LithoLink Corporation   (United States)

Author keywords

biomechanics; bone; hypercalciuria; nephrolithiasis; rodent

Indexed keywords

CALCIUM; CHLORTALIDONE; OXALIC ACID; PHOSPHORUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MINERALIZATION; BONE QUALITY; BONE STRENGTH; BONE STRUCTURE; CALCIUM EXCRETION; CONTROLLED STUDY; HYPERCALCIURIA; MALE; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; MUSCULOSKELETAL SYSTEM PARAMETERS; NONHUMAN; RAT; RAT STRAIN; RIGIDITY; STONE FORMATION; THICKNESS; TRABECULAR BONE; VERTEBRA; VERTEBRA FRACTURE;

ANIMALS; BIOMECHANICS; BONE DENSITY; CALCIFICATION, PHYSIOLOGIC; CALCIUM OXALATE; CALCIUM PHOSPHATES; CHLORTHALIDONE; FEMORAL NECK FRACTURES; FEMUR; HYPERCALCIURIA; KIDNEY CALCULI; RATS; RATS, SPRAGUE-DAWLEY; SPINE;

EID: 79960621055     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.374     Document Type: Article

References (65)

1. Bushinsky DA, Coe FL, Moe OW,. Nephrolithiasis. In:, Brenner BM, ed. The Kidney 8th ed. Philadelphia: Saunders, 1299-1349. 2008.
2. Bushinsky DA,. Recurrent hypercalciuric nephrolithiasis: does diet help? N Engl J Med. 2002; 346: 124-125. (Pubitemid 34438904)
3. Bushinsky DA, Monk RD,. Calcium. Lancet. 1998; 352: 306-311. (Pubitemid 28342192)
4. Heilberg IP, Weisinger JR,. Bone disease in idiopathic hypercalciuria. Curr Opin Nephrol Hypertens. 2006; 15: 394-402. (Pubitemid 44297982)
5. Sutton RAL, Walker VR,. Bone resorption and hypercalciuria in calcium stone formers. Metabolism. 1986; 35: 485-488. (Pubitemid 16090267)
6. Urivetzky M, Anna PS, Smith AD,. Plasma osteocalcin levels in stone disease: A potential aid in the differential diagnosis of calcium nephrolithiasis. J Urol 1988; 139: 12-14. (Pubitemid 18050726)
7. Liberman UA, Sperling O, Atsmon A, Frank M, Modan M, deVries A,. Metabolic and calcium kinetic studies in idiopathic hypercalciuria. J Clin Invest. 1968; 47: 2580-2590.
8. Weisinger JR, Alonzo E, Bellorin-Font E, et al. Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria. Kid Int. 1996; 49: 244-250. (Pubitemid 26024239)
9. Vezzoli G, Soldati L, Ardila M, et al. Urinary calcium is a determinant of bone mineral density in elderly men participating in the InCHIANTI study. Kid Int. 2005; 67: 2006-2014. (Pubitemid 40577739)
10. Giannini S, Nobile M, Dalle Carbonare L, et al. Hypercalciuria is a common and important finding inpostmenopausal women with osteoporosis. Eur J Endocrinol. 2003; 149: 209-213. (Pubitemid 37120993)
11. Asplin JR, Bauer KA, Kinder J, et al. Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis. Kidney Int. 2003; 63: 662-669. (Pubitemid 36126813)
12. Heller HJ, Zerwekh JE, Gottschalk FA, Pak CY,. Reduced bone formation and relatively increse bone resorption in absorptive hypercalciuria. Kidney Int. 2007; 71: 808-815. (Pubitemid 46624030)
13. Lauderdale DS, Thisted RA, Wen M, Favus M,. Bone mineral density and fracture among prevalent kidney stone cases in the Third National Health and Nutrition Examination Survey. J Bone Miner. 2001; 16: 1893-1898. (Pubitemid 32911497)
14. Cauley JA, Fullman RL, Stone KL, et al. Factors associated with the lumbar spine and proximal femur bone mineral density in older men. Osteoporos Int. 2005; 16: 1525-1537. (Pubitemid 41790856)
15. Melton LJI, Crowson CS, Khosla S, Wilson DM, Fallon WM,. Fracture risk among patients with urolithiasis: a population based cohort study. Kidney Int. 1998; 53: 459-464. (Pubitemid 28097864)
16. Friedman PA, Bushinsky DA,. Diuretic effects on calcium metabolism. Seminars in Nephrology. 1999; 19: 551-556. (Pubitemid 29518109)
17. Coe FL, Parks JH, Bushinsky DA, Langman CB, Favus MJ,. Chlorthalidone promotes mineral retention in patients with idiopathic hypercalciuria. Kidney Int. 1988; 33: 1140-1146.
18. Suki WN, Porter RH, Cox BG, et al. Treatment of hypoparathyroid patients with chlorthalidone. N Eng J Med. 1978; 298: 577-581. (Pubitemid 8291638)
19. Bushinsky DA, Favus MJ, Coe FL,. Mechanism of chronic hypocalciuria with chlorthalidone: reduced calcium absorption. Am J Physiol (Renal Fluid Electrolyte Physiol l6). 1984; 247: F746-F752. (Pubitemid 15178884)
20. Bushinsky DA, Asplin JR,. Thiazides reduce brushite, but not calcium oxalate, supersaturation and stone formation in genetic hypercalciuric stone-forming rats. J Am Soc Nephrol. 2005; 16: 417-424. (Pubitemid 41725137)
21. Breslau NA, Moses AM, Weiner IM,. The role of volume contraction in the hypocalciuric action of chlorothiazide. Kid Int. 1976; 10: 164-170.
22. Monk RD, Bushinsky DA,. Kidney Stones. In:, Kronenberg HM, Melmed S, Polonsky KS, Larsen PR, eds. Williams Textbook of Endocrinology 11 ed. W.B. Saunders, Philadelphia: pp. 1311-1326. 2008.
23. Pearle MS, Roehrborn CG, Pak CYC,. Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis. Journal of Endurology. 1999; 13: 679-685.
24. Ernst ME, Carter BL, Zheng S, Grimm RH,. Meta-Analysis of Dose-Response Characteristics of Hydrochlorothiazide and Chlorthalidone: Effects on Systolic Blood Pressure and Potassium. Am J Hypertens. 2010; 23: 440-446.
25. Renjmark L, Vestergaard P, Mosekilde L,. Reduced fracture risk in users of thiazide diuretics. Calc Tiss Int. 2005; 76: 167-175. (Pubitemid 41557145)
26. Feskanisch D, Willett WC, Stampfer Jm, Golditz GA,. A prospective study of thiazide use and fractures in women. Osteoporos Int. 1997; 7: 79-84. (Pubitemid 27077792)
27. La Croix AZ, Ott S, Ichikawa L, Scholes D, Barlow WE,. The Low-dose hydroclorothiazide and preservation of bone mineral density in older adults. A radomized, double-blind, placebo-controlled trial. Ann Intern Med. 2000; 133: 516-526.
28. Sigurdsson G, Franzson L,. Increased bone mineral density in a population-based group of 70-year-old women on thiazide diuretics, independent of parathyroid hormone levels. J Int Med. 2001; 250: 51-56. (Pubitemid 34208938)
29. Evan AP, Bledsoe SB, Smith SB, Bushinsky DA,. Calcium oxalate crystal localization and osteopontin immunostaining in genetic hypercalciuric stone-forming rats. Kidney Int. 2004; 65: 154-161. (Pubitemid 38037500)
30. Tsuruoka S, Bushinsky DA, Schwartz GJ,. Defective renal calcium reabsorption in genetic hypercalciuric rats. Kidney Int. 1997; 51: 1540-1547. (Pubitemid 27239910)
31. 3 in bone from genetic hypercalciuric rats. Am J Physiol (Cell Physiol). 1996; 271: C130-C135.
32. Bushinsky DA, Grynpas MD, Nilsson EL, Nakagawa Y, Coe FL,. Stone formation in genetic hypercalciuric rats. Kidney Int. 1995; 48: 1705-1713.
33. Kim M, Sessler NE, Tembe V, Favus MJ, Bushinsky DA,. Response of genetic hypercalciuric rats to a low calcium diet. Kidney Int. 1993; 43: 189-196. (Pubitemid 23167465)
34. Li X-Q, Tembe V, Horwitz GM, Bushinsky DA, Favus MJ,. Increased intestinal vitamin D receptor in genetic hypercalciuric rats: a cause of intestinal calcium hyperabsorption. J Clin Invest. 1993; 91: 661-667. (Pubitemid 23064152)
35. Bushinsky DA, Favus MJ,. Mechanism of hypercalciuria in genetic hypercalciuric rats: inherited defect in intestinal calcium transport. J Clin Invest. 1988; 82: 1585-1591. (Pubitemid 19007763)
36. Bushinsky DA, Asplin JR, Grynpas MD, et al. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats. Kidney Int. 2002; 61: 975-987. (Pubitemid 34175466)
37. Grynpas M, Waldman S, Holmyard D, Bushinsky DA,. Genetic Hypercaliuric Stone-Forming Rats Have a Primary Decrease in Bone Mineral Density and Strength. J Bone Min Res. 2009; 0: 1420-1426.
38. Asplin JR, Donahue SE, Lindeman C, Michalenka A, Strutz KL, Bushinsky DA,. Thiosulfate Reduces Calcium Phosphate Nephrolithiasis. J Am Soc Nephrol. 2009; 20: 1246-1253.
39. Bushinsky DA, Parker WR, Asplin JR,. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats. Kidney Int. 2000; 57: 550-560. (Pubitemid 30430647)
40. Bushinsky DA, Grynpas MD, Asplin JR,. Effect of acidosis on urine supersaturation and stone formation in genetic hypercalciuric stone forming rats. Kidney Int. 2001; 59: 1415-1423. (Pubitemid 32281230)
41. 3, intestinal absorption, and renal mineral conservation in male rats. Am J Physiol 246 (Renal Fluid Electrolyte Physiol 15). 1984; 246: F140-F145. (Pubitemid 14147654)
42. Werness PG, Brown CM, Smith LH, Finlayson B,. Equil2: A BASIC computer program for the calculation of urinary saturation. The Journal of Urology. 1985; 134: 1242-1244. (Pubitemid 16207045)
43. Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Muller R,. Guidelines for asessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res. 2010; 25: 1468-1486.
44. Chachra D, Kasra M, Vanin CM, MacLusky NJ, Casper RF, Grynpas M,. The effect of different hormone replacement therapy regimens on the mechanical properties of rat vertebrae. Calcif Tissue Int. 1995; 56: 130-143.
45. Kasra M, Vanin CM, MacLusky NJ, Casper RF, Grynpas MD,. Effects of different estrogen and progestin regimens on the mechanical properties of rat femur. J Orthop Res. 1997; 15: 118-123. (Pubitemid 27111209)
46. Parfitt AM, Glorieux FH, Kanis JA, et al. Bone histomorphometry nomenclature, symbols and units. Bone Min Res. 1987; 2: 595-610.
47. Bracci PM, Bull SB, Grynpas M,. Analysis of compositional bone density data using log ration transformations. Biometrics. 1998; 54: 337-349. (Pubitemid 28158809)
48. Lee LL, Lee JSC, Waldman SD, Casper RF, Grynpas MD,. Polycyclic aromatic hydrocarbons present in cigarette smoke cause bone loss in an ovariectomized rat model. Bone. 2002; 30: 917-923. (Pubitemid 34616023)
49. Vedi S, Compston J,. Bone Histomorphometry. In:, Helfrich MH, Ralston SH, eds. Bone Research Protocols. Humana Press, Totowa, NJ: pp. 283-298. 2003.
50. Griffith JF, Guglielmi G,. Vertebral Fracture. Radiologic Clinics of North America. 2010; 48: 519-529.
51. Rico H, Revukkam M, Villa LF, Arribas I, de Buergo MA,. A longitudinal study of total and regional bone mineral content and biochemical markers of bone resorption in patients with idiopathic hypercacliuria on thiazide treatment. Mineral Electrolyte Metab. 1993; 19: 337-342. (Pubitemid 24065102)
52. Jee WSS,. Integrated: bone tissue physiology: Anatomy and physiology. In:, Cowin SC, ed. 2 ed. CRC Press, New York: 2001.
53. Wasnich RD, Davis JW, He YF, Petrovich H, Ross PD,. A randomized, double-masked, placebo-controlled trial of chlorthalidone and bone loss in elderly women. Osteoporos Int. 1995; 5: 247-251.
54. Langford HG, Curb JD, Pressel S, Schneider KA,. Effect of thaizide-based therapy on serum alkaline phosphatase. Hypertension Detection dn Follow-up Group. J Hum Hypertens. 1991; 5: 333-338.
55. Adams JS, Song CF, Kantorovich V,. Rapid recovery of bone mass in hypercalciuric, osteoporotic men treated with hydrochlorothiazide. Ann Intern Med. 1999; 130: 658-660. (Pubitemid 29196200)
56. Steiniche T, Mosekilde L, Christensen MS, Melsen F,. Histomorphometric analysis of bone in idiopathic hypercalciuria before and after treatment with thiazide. APMIS. 1989; 97: 302-308. (Pubitemid 19142677)
57. Costanzo LS, Windhager EE,. Calcium and sodium transport by the distal convoluted tubule of the rat. Am J Physiol. 1978; 235: F492-F506. (Pubitemid 10221860)
58. Tonelli M, Pannu N, Manns B,. Oral Phosphate Binders in Patients with Kidney Failure. N Engl J Med. 2010; 362: 1312-1324.
59. Massry SG, Arieff AI, Coburn JW, Palmieri G, Klefman CR,. Divalent ion metabolism in patients with acute renal failure. Studies on the mechanism of hypocalcemia. Kidney Int. 1974; 5: 437-445.
60. Evan AP, Lingeman JE, Coe FL, et al. Randall plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest. 2003; 111: 607-616. (Pubitemid 36278579)
61. Bushinsky DA,. Nephrolithiasis: site of the initial solid phase. J Clin Invest. 2003; 111: 602-605. (Pubitemid 36278578)
62. Bushinsky DA, Kim M, Sessler NE, Nakagawa Y, Coe FL,. Increased urinary saturation and kidney calcium content in genetic hypercalciuric rats. Kidney Int. 1994; 45: 58-65. (Pubitemid 24045992)
63. Procino G, Mastrofrancesco L, Mira A, et al. Aquaporin 2 and Apical Calcium-Sensing Receptor: New Players in Polyuric Disorders Associated With Hypercalciuria. Seminars in Nephrology. 2008; 28: 297-305. (Pubitemid 351749755)
64. Sands JM, Naruse M, Baum M, et al. Apical extracellular calcium/polyvalent cation-sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct. The Journal of Clinical Investigation. 1997; 99: 1399-1405. (Pubitemid 27142778)
65. Renkema KY, Velic A, Dijkman HB, et al. The Calcium-Sensing Receptor Promotes Urinary Acidification to Prevent Nephrolithiasis. J Am Soc Neph. 2009; 20: 1705-1713.